Unforeseen uses of oral contraceptive pills: Exploratory study in Jordanian community pharmacies.

Since the 1960s, oral contraceptive pills (OCPs) have become globally abundant and usable by the vast majority of women [ 1 , 2 ]. According to the data, nearly all women prefer to use OCPs [ 3 ] and it is considered one of the most frequently used contraception methods [ 3 , 4 ]. In addition, OCPs have many other indications apart from their purpose as a birth control method use, such as regulation of menstruation, dysmenorrhea, endometriosis, acne treatment, and reducing the risk of endometrial, ovarian, and colon cancer [ 5 ]. In five European countries, a comprehensive study found that OCPs were rated as the most widely used method of contraception among women [ 1 ]. In Jordan, OCPs are one of the most common birth control methods, which is used by 60% of Jordanian women [ 6 ]. Improper use of medications could include misuse and abuse practices. According to the National Institute on Drug Abuse, misuse of prescription drugs means “taking a medication in a manner or dose other than prescribed; taking someone else’s prescription, even if for a legitimate medical complaint such as pain; or taking a medication to feel euphoria” [ 7 ]. Drug abuse is the use of a substance for nontherapeutic purposes to experience psychotropic (e.g., euphoric, sedative, or anxiolytic) effects [ 8 ]. OCPs are highly susceptible to be used improperly as these pills are readily available in the market and can be sold without a prescription in Jordanian Pharmacies [ 9 ]. OCPs might be improperly used, or used for other unintended indications, or used for a longer duration than intended without medical advice [ 9 ]. Besides, many types of OCPs suit a variety of individuals depending on their intended need and use. For example, some women use OCPs on a long term basis to delay aging and enhance femininity, since this is recommended by many beauty centers (unauthorized health care providers) [ 9 ]. Furthermore, the appropriateness of using OCPs depends on several factors, including a woman’s health status, age, medical history, smoking status, and other related factors [ 10 ]. Jordan pharmacy law has no regulations to restrict the prescription of OCPs, therefore, these pills can be obtained without a prescription from community pharmacies [ 6 ]. A study by Bardaweel et al. found that more than 75% of women in Jordan had consulted a doctor and received a prescription before using OCPs. A study conducted in the United Arab Emirates found that more than 92% of community pharmacists did not ask the patient any question to assess their eligibility to use oral contraceptives [ 11 ]. Whereas, both the United States and the United Kingdom have well-designed protocols to guide pharmacists in proper and safe OCPs handling [ 12 , 13 ]. It has been reported that community pharmacists play a crucial role in the management of hormonal contraceptive usage and in avoiding any improper use of the products among women [ 12 , 13 ]. On the other hand, studies from developing countries concerning pharmacists’ involvement in dispensing OCPs have shown that there are minimal assessments and suboptimal screening for the safe use of these products by patients [ 14 – 16 ]. Hence, to the authors’ knowledge, there is no documentation of OCP misuse and abuse cases and nothing regarding how pharmacists can manage it. Thus, this study aims to assess the unforeseen improper uses of OCPs observed by community pharmacists in Jordan.

Out of the total 383 completed questionnaires, three forms (0.8%) were excluded from the study due to incomplete responses. Accordingly, 380 (99.2%) of the answered questionnaires were included in the study analysis. More than half of the participating pharmacists were female (n = 210, 55.3%). The mean age of the participants was (32.58 ± 9.94) and the majority held a bachelor’s degree (n = 274, 72.2%). Regarding the participants’ experience in community pharmacy, half of them (n = 192, 50.5%) had been working for a relatively short period (i.e. less than 5 years). Most of the participants were working in pharmacies located in the capital of Jordan Amman" (n = 250, 65.8%). Regarding the participants' perceptions, around 84% (n = 319) of the pharmacy customers were classified as a middle-income social class, regardless of the province where they worked. In terms of the available facilities around the pharmacy, less than half (n = 157, 41%) of the participants reported that there were sports gyms, while 60.8% (n = 231) mentioned that there were beauty centers around the pharmacy ( Table 1 ). The majority of the participating pharmacists (n = 323, 85%) agreed that OCPs have non-contraceptive indications ( Fig 1 ). More than 80% of those pharmacists stated that OCPs could be used for the treatment of polycystic ovary syndrome, heavy periods and acne ( Fig 1 ). Assessing the pharmacist’s knowledge of the possible side effects of OCPs revealed that OCPs are associated with mood changes, increased body weight, breast enlargement and venous thromboembolism in 95.3%, 92.1%, 78.7% and 77.6%, respectively. Only, 28.7% of the participants knew that OCPs could cause gall bladder disease ( S1 Fig ). Among the participants who agreed with the presence of non-contraceptive indications for OCPs (n = 323, 85%), the horizontal column chart demonstrates the chosen indications. The participating pharmacists were asked, “if they had ever been exposed to OCPs improper use cases”. Half of them confirmed their exposure to such cases (n = 200, 53%) ( Fig 2 ), and those pharmacists provided more detailed answers about their observations using an open-ended question, which presented general themes. The majority of those pharmacists (n = 162, 81%) reported that many kinds of OCPs were used by females as emergency contraception (i.e. unlicensed OCPs), who used a very high dose of these OCPs directly after intercourse. A further ten participants suggested that OCPs were being taken 15 pills at a time, or one full pack in one go, the following intercourse. Other participants stated that OCPs were used topically for hair growth enhancement and acne treatment. Around 15% of the pharmacists reported that OCPs were being used to give a negative result for addictive drug screening tests. More detailed answers are summarized in Fig 2 . Among the participants who answered “YES” (n = 200, 52.6%) with the presence of OCPs improper use, the participants were able to write detailed answers using an open-ended question and presented as main themes in the table. The pharmacists who confirmed their exposure to the improper use of OCPS also revealed that both genders are susceptible. More than 60% of those pharmacists reported that those who improperly used OCPs were a cohort of strangers and regular customers (n = 139, 69.5%) and were aged 20–30 (n = 151, 75.5%). Friends were rated the most common source (n = 182, 91%) that encourage them to use OCPs. The OCP “levonorgestrel with ethinyl estradiol” was documented as the most susceptible product for improper use (n = 157, 78.5%), according to the participating pharmacists’ experience, followed by “drospirenone with ethinyl estradiol” and “norethisterone alone”, at 64% and 62%, respectively ( Table 2 ). Eighty-three percent (n = 317) of the participating pharmacists disclosed that they had dispensed OCPs without prescription. More than 40% (n = 154) of the study’s participants stated that those who improperly used OCPs directly asked and admitted their need for these pills, while 60% (n = 127) of pharmacists were able to suspect that an OCP customer could be an improper user from their facial and body language. In the case of suspicion for improper use, most of the pharmacists (n = 355, 93.4%) affirmed that they would not dispense these medications. Therefore, they would rather advise/clarify the side effects of these pills in order to limit the improper use of OCPs (n = 364, 95%). Further solutions that have been suggested by the participant pharmacists to limit the improper uses of OCPs are detailed in Table 3 . Multivariate logistic regression outcomes ( Table 4 ) showed a positive significant correlation (p < 0.05) between the pharmacist’s exposure to the improper use of OCPs and the following: the extent of the pharmacist’s experience (in years), the relatively low social class distribution of the pharmacy’s customers, and the presence of sport and beauty centers around the pharmacy. Significance ( p <0.05) presented in bold numbers.

This study spotlighted many unforeseen improper uses of OCPs in Jordan. Findings from this study emphasize the important role that community pharmacists have in identifying and preventing the improper uses of OCPs and also highlights the need for applying more strict monitoring procedures on the OCP handling process by both policymakers and drug regulatory institutions in Jordan. Also, the establishment of national educational programs for the Jordanian community about the safe and proper use of OCPs should be implemented. To this end, we recommend performing studies that deeply explore the reasons behind the improper use of OCPs by the users themselves, with a view to evaluate the effect of awareness campaigns about improper use, and their effects on improper use rates and prescription patterns, in collaboration with JPA and JFDA.

This study followed a descriptive cross-sectional design and the objectives were addressed via an online survey. The study was conducted in Jordan from 8th June to 27th July 2020. The online survey was developed and validated by clinical researchers to solicit anonymous responses, which were treated confidentially. The eligible participants, which included Jordanian pharmacists and trainees (who were working/training in community pharmacy) were recruited using a convenience sampling method. The inclusion criteria were explained at the start of the survey, which stated: “If you are working or training at a community pharmacy, please let us know if you would like to participate in this survey”. Participants were recruited through social media platforms (Facebook, WhatsApp, LinkedIn, and Twitter). Participants were advised that their participation in the study was voluntary and did not pose any risks. A written participant consent statement “Your participation in completing this questionnaire is highly appreciated” was given to the participants at the beginning of the survey. If the participants were willing to proceed with the survey, they approved their consent. If not, they selected “disagree to participate” and did not continue with the survey questions. Potential participants who completed the survey were considered to have given informed consent for their participation in the study. The Ethical approval for the study was obtained from the Faculty of Pharmacy, Applied Science Private University (Approval number: 2019-PHA-14). The online survey was developed after reviewing related validated surveys in the literature [ 6 , 17 , 18 ], and was designed using the general principles of good survey design [ 18 ]. Several sources were used to generate a pool of questions considered to be relevant to the objectives of the study [ 18 ]. The online survey was finally prepared using Google Forms, and although it was constructed in English, it was delivered to the participants in Arabic, the formal language of Jordan. The survey contained multiple-choice and open-ended questions and was designed to be completed within 7–10 minutes. To ensure face validity, the first draft of the survey was evaluated by fifteen independent academic staff members who had previous experience in OCPs related work and research studies. A statistician was also involved at this stage of the evaluation. All the provided comments and feedback were considered and incorporated where appropriate to prepare the final version of the survey. The survey was then translated from English into Arabic and then back-translated by two senior academic staff members who were considered fluent in both languages. The questions were free from medical jargon or difficult terminology. Finally, the survey was piloted via a sample of 25 academic and 25 non-academic participants. This stage of the study was conducted to enhance clarity, readability, understandability, and confirm the study’s applicability to Jordanian community pharmacists. Internal consistency reliability was tested by the Cronbach’s alpha coefficient, which equaled 0.89. The final version of the survey contained three parts. Part A comprised of twelve questions, which included sociodemographic information. Part B consisted of four questions comprising details of the participants’ knowledge and beliefs toward the use of OCPs. The questions regarding knowledge were mainly concerned with the presence of non-contraceptive indications and the side effects of OCPs. Here, the participants were able to choose more than one option. Part C focused on the pharmacist's experience and practice towards the improper use of OCPs. This consisted of ten multiple-choice questions and one open short essay. The pharmacists who confirmed their exposure to suspected cases of the improper use of OCPs provided more detailed answers about their observations in the open-ended question, which presented us with general themes. In the last section, the participants were asked if they had been exposed before to any improper use practices relating to OCPs. When they answered “yes”, an open-ended question was designed to allow the participant to explain in detail their experience of the improper use of OCPs. In addition, they were also asked about the proper methods to deal with such practices. A copy of the final version of the survey (in both the original language and English) can be seen in S1 and S2 Appendixs. The most recent statistics released by the Jordanian Pharmacist’s Association (JPA) show that there were 22,667 registered pharmacists by February 2019 [ 19 ]. This statistical report reveals the Jordanian pharmacists' demographics, according to gender (i.e. females n = 14,587, 64%), the province where they work (i.e. Amman n = 15,866, 70%), mean age (30.7 ± 8.2 years old) and also showed that the majority had a bachelor’s degree (n = 17,667, 77.6%) [ 19 ]. Based on this data, the sample size was calculated using a margin of error of 5%, a confidence level of 95%, and a response distribution of 50%, giving a minimum sample size of 378 pharmacists [ 20 ]. The decision was made to increase the number to around 380 pharmacists to take into account missing responses and other unknown issues that might arise. The sample was taken from the total number of registered pharmacists in Jordan (a homogeneous sample). According to the sample size calculations, the convenience homogeneous sample represents the whole population and it can be generalized on a national level [ 21 ]. The completed surveys were extracted from Google Forms as an Excel sheet and were then exported to Statistical Package for Social Sciences version 24.0 (SPSS® Inc., Chicago, IL, USA) for the statistical analysis. The descriptive statistics included percentages, means, and frequency distribution, which were calculated for each question. Descriptive and univariate correlation analyses using Pearson correlation coefficient (r) were used for the correlation, which was conducted at a 5% significance level. A p -value of < 0.05 represented a significant difference. The answers to the open-ended question were transferred to an Excel sheet, analyzed and categorized for themes, and presented as frequencies and percentages. Factors affecting the improper use of OCPS were analyzed using simple and multivariate linear regression.

(DOCX) Click here for additional data file. (DOCX) Click here for additional data file. (TIF) Click here for additional data file.